1. Introduction {#sec1}
===============

Acute nontraumatic headache (NTH) is a common chief complaint, and 8--13% of patients have serious intracranial causes at the emergency department (ED) \[[@B1]--[@B3]\]. The emergency physician (EP) makes a diagnosis by evaluating the clinical presentation, physical examination, and red flag signs to choose the appropriate further investigation and treatment. Therefore, the challenge for the EP is to evaluate and diagnose a life-threatening headache because high mortality rates and severe disabilities were reported \[[@B4]\]. Errors in diagnosing serious intracranial cause usually occur at the ED \[[@B4]\]. Serious intracranial causes that the EP must not misdiagnose are acute subarachnoid hemorrhage (SAH), acute ischemic stroke, acute intracerebral hemorrhage (ICH), neoplasm, intracranial infection, cerebral venous sinus thrombosis, hypertensive encephalopathy, arteriovenous malformation (AVM), hydrocephalus, and giant cell arteritis \[[@B1], [@B2], [@B5]\]. The aim of this study was to identify the predictive factors and develop a clinical prediction score to identify serious intracranial cause in acute NTH patients.

2. Methods {#sec2}
==========

2.1. Study Design and Setting {#sec2.1}
-----------------------------

A retrospective chart review study was conducted at the ED of Songklanagarind Hospital, which is a tertiary university hospital in southern Thailand. The data were collected from January 2013 to June 2018 and followed the methods of Tantarattanapong et al. \[[@B6]\]. The inclusion criteria were (1) age ≥15 years and visited the ED with the chief complaint of acute NTH and (2) the final diagnosis was a serious intracranial cause that included acute SAH, acute ischemic stroke, acute ICH, neoplasm, intracranial infection, cerebral venous sinus thrombosis, hypertensive encephalopathy, AVM, hydrocephalus, or giant cell arteritis. The definition for diagnosis of acute NTH was according to the International Classification of Headache Disorders, 3^rd^ edition (beta version) \[[@B7]\]. The exclusion criteria were (1) patients diagnosed as serious intracranial cause who were referred from other hospitals, (2) pregnancy, (3) history of traumatic brain injury within the previous 30 days \[[@B8]\], (4) previous intracranial pathology, (5) incomplete medical records, and (6) lost to follow-up.

The study was approved by the Institutional Ethics Committee Board of the Faculty of Medicine at Prince of Songkla University. Informed consent was waived according to our institutional review board protocol because the research presented no more than minimal risk to the participants and did not involve procedures for which written consent is normally required outside the research context. All research information was kept confidential and was accessed only by the researcher and the assistant.

When the patients presented at the ED, the EP evaluated the history, physical examination, and used red flag signs to classify the risk for diagnosis between primary and secondary headache. The red flag signs were age \>50 years, abrupt or sudden onset, positional provocation, systemic symptoms (fever and weight loss), secondary risk factors (i.e., HIV infection and malignancy), neurological symptoms (i.e., alteration of consciousness and focal neurological deficit), and papilledema \[[@B9]\]. The provisional diagnosis was made by the EP after complete history taking and physical examination. The patients who had red flag signs needed further investigations such as neuroimaging or lumbar puncture as indicated. The results of imaging were reported by the radiologist. If the patients had a serious intracranial cause, the EP consulted the specialists (i.e., internist, neuromedical, and neurosurgical physicians) to confirm the final diagnosis and treatment. If the patients did not have red flag signs, they were followed up at the medicine outpatient department to confirm a final diagnosis.

2.2. Data Collection {#sec2.2}
--------------------

The collected data from the medical records included the patient baseline characteristics, history taking, physical examination, red flag signs, provisional diagnosis, investigations, and final diagnosis. The patients were then categorized into serious intracranial headache and nonserious intracranial headache groups.

2.3. Outcome Measurements {#sec2.3}
-------------------------

The primary outcome was identification of the predictive factors of serious intracranial cause in acute NTH patients. The secondary outcome was to develop a clinical prediction score to identify serious intracranial cause in acute NTH patients.

2.4. Statistical Analysis {#sec2.4}
-------------------------

The *R* software, version 3.2.2, was used for the statistical analysis. The median values were calculated for continuous variables, while percentages were calculated for discrete variables. A bivariate analysis was used to analyze the baseline characteristics, clinical presentation, physical examination, and red flag signs. The data were compared between serious and nonserious intracranial headache. Continuous variables were compared using the Mann--Whitney *U* test. Categorical variables were compared using the *χ*^2^ or Fisher\'s exact test. A binary multivariate logistic regression was used to identify the significant predictive factors associated with serious intracranial headache. Statistical significance was defined as *p* ≤ 0.05, and the results are presented as odds ratio (OR) with 95% confidence interval (CI). The clinical predictive score for serious intracranial cause was analyzed by coefficients from the multivariate logistic regression to plot a receiver operating characteristic (ROC) curve. A plot of sensitivity vs. 1 − specificity gave rise to the ROC curve.

3. Results {#sec3}
==========

A total of 2,372 patients visited the ED with the chief complaint of acute NTH. A total of 1,918 patients were excluded, and 454 patients met the inclusion criteria ([Figure 1](#fig1){ref-type="fig"}). One hundred fifty-eight (34.80%) patients had red flag signs, and 88 (19.38%) patients had a final diagnosis of serious intracranial headache.

The baseline characteristics, clinical presentations, and physical examinations are shown in [Table 1](#tab1){ref-type="table"}. Serious intracranial headache had a higher rate of HIV infection (8% vs. 1.4%, *p*=0.003) and malignancy (15.9% vs. 5.7%, *p*=0.003) compared to nonserious headache. Furthermore, 2.3% and 3.4% of serious intracranial headache patients had taken prednisolone and hormone therapy, respectively.

In the serious intracranial headache group, the clinical presentations of gradual onset, abrupt onset, duration of headache \>1 week, awakening pain, worst headache ever, neck pain, nausea/vomiting, fever, and seizure presented in 62.5%, 37.5%, 25%, 47.7%, 87.5%, 33%, 64.8%, 25%, and 8% of the cases, respectively, with statistical significance.

On physical examination, the patients in the serious intracranial headache group had abnormal neurological examination more than the patients in the nonserious intracranial headache group: altered consciousness (6.8% vs. 0.3%, *p* \< 0.001), localizing neurological deficit (22.7% vs. 3.6%, *p* \< 0.001), and stiffness of neck (17% vs. 1.1%, *p* \< 0.001) ([Table 1](#tab1){ref-type="table"}).

In 454 patients with acute nontraumatic headache, 158 (34.8%) patients had red flag signs and needed further investigations. The significant red flag signs in serious intracranial headache were abrupt onset (37.5%), systemic symptoms (25%), secondary risk factors (23.9%), and neurological deficit (33%) ([Table 2](#tab2){ref-type="table"}). For serious intracranial headache, 88 patients had red flag signs and the investigations performed were CT (100%), CTA (18.2%), MRI (26.1%), and lumbar puncture (29.5%). The results of the investigations are shown in [Table 2](#tab2){ref-type="table"}. In the nonserious intracranial headache group of 366 patients, 70 (19.12%) patients had red flag signs and needed further investigations ([Table 2](#tab2){ref-type="table"}) and the final diagnosis was nonserious intracranial headache.

The provisional diagnosis of serious intracranial causes by the EP was in 84 patients, and a misdiagnosis occurred in 4 (4.8%) patients who had brain metastasis, subacute subdural hemorrhage, acute ischemic stroke, and giant call arteritis. The top five final diagnoses of serious intracranial causes were neoplasm, intracranial infection, ICH, acute SAH, and ischemic stroke ([Table 3](#tab3){ref-type="table"}).

Multivariate analysis revealed that the significant predictive factors to identify serious intracranial causes in acute NTH patients were abrupt onset, awakening pain, duration of headache \>1 week, fever, worst headache ever, alteration of consciousness, and localizing neurological deficit ([Table 4](#tab4){ref-type="table"}).

The significant predictive factors were developed into a clinical prediction score for serious intracranial cause ([Table 5](#tab5){ref-type="table"}). A score \<3 points means the patient is less likely to have a serious intracranial cause, and a score ≥3 points means the patient is likely to have a serious intracranial cause. The sensitivity and specificity were 87.50% (95% CI 78.73--93.59%) and 87.70% (95% CI 83.90--90.89%), respectively. From [Figure 2](#fig2){ref-type="fig"}, the area under the curve is 0.933.

4. Discussion {#sec4}
=============

The incidence of serious intracranial cause in this study was 19.38%, which was higher than that reported in other studies (8.9--13%) \[[@B1]--[@B3]\]. The common causes of serious intracranial causes in acute NTH were neoplasm and intracranial infection, which were different from other studies that reported acute SAH as the most common cause \[[@B1]--[@B3]\].

The significant factors of serious intracranial causes in acute NTH in this study were the same factors as the red flag signs, which consisted of abrupt onset, systemic symptoms, secondary risk factors, and neurological deficit. These factors were associated with the most common etiology of this study. From a study by Lamont, the red flag signs, which consisted of papilledema, drowsiness, confusion, memory impairment or loss of consciousness, and paralysis, were quite similar to this study \[[@B10]\].

It is interesting to note that 95% had at least two of the four symptoms of headache, fever, neck stiffness, and altered mental status, which could be diagnosed as meningitis from the study by van de Beek \[[@B11]\]. According to a study by Pfund, if the patient had duration of headache from one week to a month and severe (worst) headache pain, it had a high diagnostic yield for the diagnosis of serious intracranial neoplasm \[[@B12]\]. From these two studies, the associated symptoms were quite similar to the multivariate analysis by logistic regression in this study, which demonstrated that fever (OR 6.01, 95% CI 2.07--17.46), alteration of consciousness (OR 13.55, 95% CI 2.07--88.88), duration of headache \>1 week (OR 10.59, 95% CI 2.9--38.7), and severe (worst) headache pain (OR 12.95, 95% CI 5.69--29.45) were the significant factors of serious intracranial cause in acute NTH patients.

Abrupt onset (OR 7.96, 95% CI 2.77--22.91), alteration of consciousness (OR 13.55, 95% CI 2.07--88.88), and localizing neurological deficit (OR 5.28, 95% CI 1.6--17.46) were the same significant predictive factors to diagnose serious intracranial cause as Locker \[[@B3]\]. The worst headache ever (OR 12.95, 95% CI 5.69--29.45) was the significant factor in a previous study, which demonstrated an association with a diagnosis of acute SAH (OR 76.5, 95% CI 6.0--982.9) \[[@B9]\].

In clinical practice, diagnostic algorithms have been structured for four clinical scenarios at the ED. Scenario 1 aims to include acute SAH, scenario 2 aims to include the expression of intracranial infection, scenario 3 aims to include intracranial neoplasm or temporal arteritis, and scenario 4 aims to include benign headache \[[@B13]\]. In scenarios 1--3, the clinical presentations are the same as the clinical presentation scoring system in this study to diagnose a serious intracranial cause. From a study by Grimaldi et al., 18 of 77 patients in scenarios 1, 2, and 3 had malignant headache \[[@B8]\].

This study developed a clinical prediction score to identify serious intracranial cause. Plots of sensitivity versus 1-specificity had a sensitivity and specificity of 87.50% (95% CI 78.73--93.59%) and 87.70% (95% CI 83.90--90.89%), respectively. The area under the curve was 0.933, which means this study had good overall test accuracy because a range between 0.9 and 1.0 indicates that the cutoff point to diagnosis serious intracranial cause is excellent. The cutoff point at 3 can divide the patients into two groups \[[@B14]\]. If the score is \<3 of 10 points, it means the patient is less likely to have a serious intracranial cause, and a score ≥3 of 10 points means the patient is likely to have a serious intracranial cause.

The clinical prediction score in this study was developed from significant factors of the red flag signs. This practical scoring system facilitated the EP, so as to categorize patients as either serious or nonserious intracranial causes of acute NTH patients. Then, the EP made it easy to decide whether further investigations were required. However, the clinical prediction score, for serious intracranial causes, of this study had limitations, firstly because of a lower sensitivity than other studies \[[@B3], [@B13]\]. Additionally, an important bias in this study was the retrospective design, wherein the majority of the nonserious intracranial causes for patients were not completely investigated, such as imaging or lumbar puncture. Because of this, final diagnosis of some patients, in this group, was not fully established. Therefore, a well-designed prospective study should be conducted to overcome this limitation.

5. Conclusions {#sec5}
==============

The EP obtains patient information from careful history taking and a physical examination. The EP should consider a diagnosis of serious intracranial cause in acute NTH patients who present with abrupt onset, duration of headache \>1 week, awakening pain, fever, worst headache ever, alteration of consciousness, and localizing neurological deficit.
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###### 

Baseline characteristics, clinical presentation, and physical examination.

  Characteristic                    Nonserious intracranial headache (366 patients)   Serious intracranial headache (88 patients)   *p* value
  --------------------------------- ------------------------------------------------- --------------------------------------------- -----------
  Age, years, median (IQR)          54.5 (42, 70)                                     51 (40, 64.2)                                 0.157
  Male                              131 (35.8)                                        41 (46.6)                                     0.08
                                                                                                                                    
  *Comorbidity*                                                                                                                     
  Diabetic mellitus                 42 (11.5)                                         12 (13.6)                                     0.705
  Hypertension                      118 (32.2)                                        28 (31.8)                                     1
  Hyperlipidemia                    84 (23)                                           18 (20.5)                                     0.718
  Atrial fibrillation               12 (3.3)                                          1 (1.1)                                       0.478
  Ischemic heart disease            17 (4.6)                                          3 (3.4)                                       0.777
  Cerebrovascular disease           29 (7.9)                                          8 (9.1)                                       0.887
  HIV infection                     5 (1.4)                                           7 (8)                                         0.003
  Malignancy                        21 (5.7)                                          14 (15.9)                                     0.003
                                                                                                                                    
  *Current medication*                                                                                                              
  ASA                               46 (12.6)                                         7 (8)                                         0.305
  Clopidogrel                       3 (0.8)                                           0 (0)                                         1
  Anticoagulant                     11 (3)                                            4 (4.5)                                       0.505
  Prednisolone                      0 (0)                                             2 (2.3)                                       0.037
  Hormonal therapy                  1 (0.3)                                           3 (3.4)                                       0.024
                                                                                                                                    
  *Clinical presentation*                                                                                                           
  Gradual onset                     308 (84.2)                                        55 (62.5)                                     \<0.001
  Abrupt onset                      58 (15.8)                                         33 (37.5)                                     \<0.001
  Duration of headache \>1 week     34 (9.3)                                          22 (25)                                       \<0.001
  Occipital pain                    60 (16.4)                                         21 (23.9)                                     0.137
  Pain score                        7 (5, 8)                                          10 (8, 10)                                    \<0.001
  Awakening pain                    41 (11.2)                                         42 (47.7)                                     \<0.001
  Worst headache ever               61 (16.7)                                         77 (87.5)                                     \<0.001
  Neck pain                         61 (16.7)                                         29 (33)                                       \<0.001
  Nausea/vomiting                   149 (40.7)                                        57 (64.8)                                     \<0.001
  Fever                             26 (7.1)                                          22 (25)                                       \<0.001
  Positional provocation            5 (1.4)                                           4 (4.5)                                       0.076
  Seizure                           5 (1.4)                                           7 (8)                                         0.003
                                                                                                                                    
  *Physical examination*                                                                                                            
  BT, °C, median (IQR)              36.6 (36.2, 36.9)                                 36.8 (36.2, 37.3)                             0.008
  SBP, mmHg, median (IQR)           144 (128, 161)                                    140.5 (127, 162)                              0.621
  PR, bpm, median (IQR)             76 (68, 88)                                       77 (67.5, 88.2)                               0.89
  RR, breath/min, median (IQR)      20 (20, 24)                                       24 (20, 24)                                   0.018
  SpO~2~, %, median (IQR)           99 (98, 100)                                      99 (97, 100)                                  0.006
  Altered consciousness             1 (0.3)                                           6 (6.8)                                       \<0.001
  Localizing neurological deficit   13 (3.6)                                          20 (22.7)                                     \<0.001
  Stiffness of neck                 4 (1.1)                                           15 (17)                                       \<0.001

Data are presented as *n* (%) unless indicated otherwise. *p* values \<0.05 are statistically significant. IQR = interquartile range; HIV = human immunodeficiency virus; ASA = aspirin; BT = body temperature; SBP = systolic blood pressure; PR = pulse rate; bpm = beats per minute; SpO~2~ = oxygen saturation.

###### 

Comparison of red flag signs and investigations.

                                     Nonserious intracranial headache (366 patients)   Serious intracranial headache (88 patients)   *p* value
  ---------------------------------- ------------------------------------------------- --------------------------------------------- -----------
  *Red flag signs*                                                                                                                   
  Age \>50 years                     231 (63.1)                                        48 (54.5)                                     0.174
  Abrupt onset                       58 (15.8)                                         33 (37.5)                                     \<0.001
  Positional provocation             5 (1.4)                                           4 (4.5)                                       0.076
  Systemic symptoms                  26 (7.1)                                          22 (25)                                       \<0.001
  Secondary risk factors             26 (7.1)                                          21 (23.9)                                     \<0.001
  Neurological deficit               13 (3.6)                                          29 (33)                                       \<0.001
                                                                                                                                     
  *Investigations*                                                                                                                   
  Performed CT brain                 70 (19.1)                                         88 (100)                                      \<0.001
                                                                                                                                     
  *CT brain results*                                                                                                                 
  Subarachnoid hemorrhage            0 (0)                                             12 (13.6)                                     \<0.001
  Intracerebral hemorrhage           0 (0)                                             15 (17.0)                                     \<0.001
  Infarction                         0 (0)                                             6 (6.8)                                       \<0.001
  Tumor with/without complications   0 (0)                                             21 (23.9)                                     \<0.001
  Venous sinus thrombosis            0 (0)                                             4 (4.5)                                       0.001
  Hydrocephalus                      0 (0)                                             1 (1.1)                                       0.194
  Brain abscess                      0 (0)                                             1 (1.1)                                       0.194
  Within normal limits               70 (19.1)                                         28 (31.8)                                     0.014
  Performed CTA                      0 (0)                                             16 (18.2)                                     \<0.001
                                                                                                                                     
  *CTA results*                                                                                                                      
  AVM                                0 (0)                                             6 (6.8)                                       \<0.001
  Aneurysm                           0 (0)                                             7 (8)                                         \<0.001
  Within normal limits               0 (0)                                             3 (3.4)                                       0.007
  Performed MRI                      0 (0)                                             23 (26.1)                                     \<0.001
                                                                                                                                     
  *MRI results*                                                                                                                      
  Leptomeningeal enhancement         0 (0)                                             1 (1.1)                                       0.194
  Focal meningoencephalitis          0 (0)                                             1 (1.1)                                       0.194
  Brain tumor/metastasis             0 (0)                                             17 (19.3)                                     \<0.001
  Cerebral infarction                0 (0)                                             2 (2.3)                                       0.037
  Venous sinus thrombosis            0 (0)                                             1 (1.1)                                       0.194
  AVM                                0 (0)                                             1 (1.1)                                       0.194
  Performed lumbar puncture          5 (1.4)                                           26 (29.5)                                     \<0.001
                                                                                                                                     
  *CSF findings*                                                                                                                     
  Bacterial meningitis               0 (0)                                             2 (2.3)                                       0.037
  Viral meningitis                   0 (0)                                             12 (13.6)                                     \<0.001
  Fungal meningitis                  0 (0)                                             6 (6.8)                                       \<0.001
  Eosinophilic meningitis            0 (0)                                             1 (1.1)                                       0.194
  Blood                              0 (0)                                             1 (1.1)                                       0.194
  Normal profile                     5 (1.4)                                           4 (4.5)                                       0.076
                                                                                                                                     
  *Pathogens*                                                                                                                        
  Beta Streptococcus group B         0                                                 1                                              
  *Pseudomonas aeruginosa*           0                                                 1                                              
  *Cryptococcus neoformans*          0                                                 5                                              
  Human herpes virus                 0                                                 2                                              

Data are presented as *n* (%) unless indicated otherwise. *p* values \<0.05 are statistically significant. CT = computed tomography; CTA = computed tomographic angiography; AVM = arteriovenous malformation; MRI = magnetic resonance imaging.

###### 

Final diagnosis of serious intracranial cause of acute nontraumatic headache.

  Final diagnosis                    No. of patients (%)
  ---------------------------------- ---------------------
  Neoplasm                           23 (26.1)
  Intracranial infection             22 (25.0)
  Intracerebral hemorrhage           15 (17.0)
  Acute subarachnoid hemorrhage      13 (14.8)
  Ischemic stroke                    6 (6.8)
  Cerebral venous sinus thrombosis   5 (5.7)
  Hypertensive encephalopathy        1 (1.1)
  Arteriovenous malformation         1 (1.1)
  Hydrocephalus                      1 (1.1)
  Giant cell arteritis               1 (1.1)
  Total                              88 (100)

###### 

Multivariable logistic regression model for the predictive factors of serious intracranial cause in acute nontraumatic headache.

  Variables                         Crude OR (95% CI)      Adjusted OR (95% CI)   *p* value
  --------------------------------- ---------------------- ---------------------- -----------
  Abrupt onset                      3.19 (1.9--5.33)       7.96 (2.77--22.91)     \<0.001
  Awakening pain                    7.24 (4.26--12.29)     3.14 (4.15--6.82)      0.004
  Duration \>1 week                 4.06 (2.12--7.78)      10.59 (2.9--38.7)      \<0.001
  Fever                             4.36 (2.33--8.15)      6.01 (2.07--17.46)     \<0.001
  Worst headache ever               35 (17.57--69.71)      12.95 (5.69--29.45)    \<0.001
  Alteration of consciousness       40.33 (11.74--138.6)   13.55 (2.07--88.88)    0.002
  Localizing neurological deficit   8.36 (3.96--17.63)     5.28 (1.6--17.46)      0.019

*p* values \<0.05 are statistically significant. OR = odds ratio; CI = confidence interval.

###### 

Clinical prediction scores for serious intracranial cause in acute nontraumatic headache.

  Predictive factors                Points
  --------------------------------- --------
  Abrupt onset                      1
  Awakening pain                    1
  Duration \>1 week                 1
  Fever                             1
  Worst headache ever               2
  Alteration of consciousness       3
  Localizing neurological deficit   1
  Total                             10

Note: a score of ≥3 points is predictive of serious intracranial cause.
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